跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 8,853 条关于
“developmental epileptic encephalopathy”
全部
8,853
临床试验
6,585
药物
107
机构
128
资讯
2,033
去年
CAP-002 Receives FDA Orphan Drug Designation for STXBP1-Related Developmental and Epileptic Encephalopathy
9个月前
Praxis Precision Medicines to Showcase Epilepsy Pipeline at AES 2025 with Full RADIANT Study Results
去年
Bright Minds Biosciences Appoints Stephen Collins as Chief Medical Officer to Advance CNS Therapies
去年
UCB's Fenfluramine Achieves Positive Phase 3 Results in Ultra-Rare CDKL5 Deficiency Disorder
8个月前
Bright Minds Biosciences Set to Release Phase 2 Results for BMB-101 in Drug-Resistant Epilepsy
去年
CAP-002 Gene Therapy Receives FDA Orphan Drug Designation for STXBP1 Disorder
去年
Biohaven's BHV-7000 Shows Promising Safety and Efficacy Profile for Epilepsy Treatment
7个月前
Tenacia Biopharmaceuticals Partners with Golden Age Health to Launch First CDKL5 Deficiency Disorder Treatment in China
上个月
Personalized ASO Gene Therapy Dramatically Reduces Seizures and Restores Walking in Children with SCN2A-Related Epilepsy
2年前
Bright Minds Biosciences Advances BMB-101 for Drug-Resistant Epilepsy in Phase 2 Trial
第 1 页，共 204 页
上一页
下一页
